FIG. 2. Effectsof Nilotinib on TNF-α protein levels (A), TGF-β1 mRNA levels (B) and TNF-α mRNA levels (C), in the liver tissues of rats with liver fibrosis. C: Control normal, O: Olive control group, CN: Nilotinib control group, F: Liver fibrosis group, FN: Liver fibrosis treated with Nilotinib (10 mg/kg body weight), the data represent mean±SD. ap<0.001 versus groups C, O and CN.bp<0.001 versus group F.
